Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LONDON, Nov. 21, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and...
-
LONDON and CARLSBAD, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and...
-
- Morgan Stanley 15th Annual Global Healthcare Conference on 13 September - - Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series on 27 September - LONDON, Sept. 05,...
-
- Epidiolex® NDA submission process underway - - Conference call today at 4:30 p.m. EDT - LONDON and CARLSBAD, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW,...
-
LONDON, July 24, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel...
-
LONDON, June 07, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel...
-
– Pharmaceutical formulation of cannabidiol significantly reduced convulsive seizure frequency in children on multiple anti-epileptic drugs with poor seizure control – – First...
-
– Dr. Volker Knappertz appointed Chief Medical Officer –– Professor Ben Whalley to join as Head of Discovery Research – LONDON, May 15, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH)...
-
GW Pharmaceuticals plc Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress
- Epidiolex® NDA submission expected mid-year -- New data in Lennox-Gastaut syndrome presented at the American Academy of Neurology -- Conference call today at 4:30 p.m. EDT- LONDON, May 09, 2017 ...
-
LONDON, May 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel...